The relationship between transforming growth factor-β1, vascular endothelial growth factor, nitric oxide and Hashimoto's thyroiditis

International Immunopharmacology

Volumn 9, Issue 2, 2009, Pages 212-215

  Vural, Pervin ^a   Degirmencioglu, Sevgin ^a   Erden, Sacide ^a   Gelincik, Asli ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Autoimmunity; Hashimoto's thyroiditis; Nitric oxide; TGF 1; VEGF

Indexed keywords

NITRIC OXIDE; THYROXINE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SPECTROPHOTOMETRY;

ADULT; FEMALE; HASHIMOTO DISEASE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; THYROID GLAND; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 58249145184     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.11.003     Document Type: Article

References (34)

1. Klecha A.J., Barriero Arcos M.L., Frick L., Genaro A.M., and Cremaschi G. Immune-endocrine interactions in autoimmune thyroid disease. Neuroimmunomodulation 15 (2008) 68-75
2. Stassi G., and De Maria R. Autoimmune thyroid disease: a new models of cell death in autoimmunity. Nat Rev i{dotless}mmunol 2 (2002) 195-204
3. Paschke R., Schuppert F., Taton M., and Velu T. Intrathyroidal cytokine gene expression profiles in autoimmune thyroiditis. J Endocrinol 141 (1994) 309-315
4. H1 cytokine in autoimmune thyroiditis. Immunol Lett 71 (2000) 73-77
5. Prud'homme G.J., and Piccirillo C.A. The inhibitory effects of transforming growth factor-beta-1 (TGF-β1) in autoimmune disease. J Autoimmun 14 (2000) 23-42
6. Govinden R., and Bhoola K.D. Genealogy, expression, and cellular function of transforming growth factor-beta. Pharmacol Ther 98 (2000) 257-265
7. Petrovaara L., Kaipainen A., Mustonen T., Orpana A., Ferrara N., Saksela O., et al. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J Biol Chem 269 (1994) 6271-6274
8. Aoki C.A., Borchers A.T., Li M., Flavell R.A., Bowlus C.L., Ansari A.A., et al. Transforming growth factor β (TGF-β) and autoimmunity. Autoimmun Rev 4 (2005) 450-459
9. Guimaraes V.C., Quintans J., Fisfalen M.E., Straus F.H., Fields P.E., Medeiros-Neto G., et al. Immunosuppression of thyroiditis. Endocrinology 137 (1996) 2199-2207
10. Akinci B., Comlekci A., Yener S., Bayraktar F., Demir T., Ozcan M.A., et al. Hashimoto's thyroiditis, but not treatment of hypothyroidism, is associated with altered TGF-β1 levels. Arch Med Res 39 (2008) 397-401
11. Ma D., Zhu X., Zhao P., Zhao C., Li X., Zhu Y., et al. Profile of Th17 cytokines (Il-17, TGF-beta, IL-6) and Th1 cytokine (IFN-gamma) in patients with immune thrombocytopenic purpura. Ann Hematol 87 (2008) 899-904
12. Hammad A.M., Youssef H.M., and Al-Arman M.M. Transforming growth factor beta 1 in children with systemic lupus erythematosus: a possible relation with clinical presentation of lupus nephritis. Lupus 15 (2006) 608-612
13. Inoue M., Itoh H., Ueda M., Naruko T., Kojima A., Komatsu R., et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions. Possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 98 (1998) 2108-2116
14. Turner H.E., Haris A.L., Melmed S., and Wass J.A.H. Angiogenesis in endocrine tumors. Endocr Rev 24 (2003) 600-632
15. Widder J., Dorfinger K., Wilfing A., Trieb K., Pirich K., Loebenstein R., et al. The immunoregulatory influence of transforming growth factor beta in thyroid autoimmunity: TGF beta inhibits autoreactivity in Graves' disease. J Autoimmun 4 (1991) 689-701
16. Donckier J.E., Michel L., Havaux X., and Van Beneden R. Interrelated overexpression of endothelial and inducible nitric oxide synthases, endothelin-1 and angiogenic factors in human papillary thyroid carcinoma. Clin Endocr 64 (2006) 703-710
17. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
18. Spinella F., Rosano L., Di Castro V., Natali P.G., and Bagnato A. Endothelin-1 induces vascular endothelial growth factor-1α in ovarian carcinoma cells. J Biol Chem 277 (2002) 27850-27855
19. Nose F., Ishikawa T., Fujiwara M., and Okayasu I. Upregulation of cyclooxygenase-2 expression in lymphocytic thyroiditis and thyroid tumors: significant correlation with inducible nitric oxide synthase. Am J Clin Pathol 117 (2002) 546-551
20. Baskol G., Atmaca H., Tanriverdi F., Baskol M., Kocer D., and Bayram F. Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Exp Clin Endocrinol Diabetes 115 (2007) 1-5
21. Grisham M.B., Johnson G.G., Gautreaux M.D., and Berg R.D. Measurement of nitrate and nitrite in extracellular fluids: a window to systemic nitric oxide metabolism. Methods: A companion to methods in enzymology 7 (1995) 84-90
22. Hill N., and Sarvetnick N. Cytokines: promoters and dampeners of autoimmunity. Curr Opin Immunol 14 (2002) 791-797
23. Gorelik L., Constant S., and Favell R.A. Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J Exp Med 195 (2002) 1499-1505
24. Heath V.L., Murphy E.E., Crain C., Tomlinson M.G., and O'Garra A. TGF-beta1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression. Eur J Immunol 30 (2000) 2639-2649
25. Shrikant P., Lee S.J., Kalvakolanu I., Ransohoff R.M., and Benveniste E.N. Stimulus-specific inhibition of intracellular adhesion molecule-1 gene expression by TGF-beta. J Immunol 157 (1996) 892-900
26. Winkler M.K., and Beveniste E.N. Transforming growth factor-beta inhibition of cytokine-induced vascular cell adhesion molecule-1 expression in human astrocytes. Glia 22 (1998) 171-179
27. Yamada H., Watanabe M., Nanba T., Akamizu T., and Iwatani Y. The +869T/C polymorphism in the transforming growth factor-β1 gene is associated with the severity and intractibility of autoimmune thyroid disease. Clin Exp Immunol 151 (2008) 379-382
28. Marazuela M., Garcia-Lopez M.A., Figueroa-Vega N., de la Fuente H., Alvarado-Sanchez B., Monsivias-Urenda A., et al. Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab 91 (2006) 3639-3646
29. Chung H.T., Pae H.O., Choi B.M., Billiar T.R., and Kim Y.M. Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 282 (2001) 1075-1079
30. Van't Hof R.J., and Ralston S.H. Nitric oxide and bone. Immunology 103 (2001) 255-256
31. Nagy G., Clark J.M., Buzas E.I., Gorman C.L., and Cope A.P. Nitric oxide, chronic inflammation and autoimmunity. Immunol Lett 111 (2007) 1-5
32. Kventy J., Heldgaard P.E., Bladbjerg E.M., and Gram J. Subclinical hypothyroidism is associated with low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf) 61 (2004) 232-238
33. Jebreel A., England J., Bedford K., Murphu J., Karsai L., Atkin, and S., Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid disease. Int J Pathol 88 (2007) 271-277
34. Itaka M., Miura S., Yamanaka K., Kawasaki S., Kitahama S., Kawakami Y., et al. Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab 83 (1998) 3908-3912